IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0813577
(2001-03-21)
|
발명자
/ 주소 |
|
출원인 / 주소 |
- Advanced Medical Applications, Inc.
|
대리인 / 주소 |
Carter, Deluca, Farrell & Schmidt, LLP
|
인용정보 |
피인용 횟수 :
86 인용 특허 :
140 |
초록
▼
An ultrasonic catheter drug delivery device comprises an ultrasound transducer to produce ultrasonic waves, which transducer is mechanically attached to a catheter body or chamber. The ultrasonic transducer has a distal tip with a distal radiation surface, and when a therapeutic agent from a fluid s
An ultrasonic catheter drug delivery device comprises an ultrasound transducer to produce ultrasonic waves, which transducer is mechanically attached to a catheter body or chamber. The ultrasonic transducer has a distal tip with a distal radiation surface, and when a therapeutic agent from a fluid source is directed to the catheter body or chamber, the radiation surface creates ultrasonic pressure and delivers liquid and simultaneously ultrasonic energy to a patient's vascularity or a selected body lumen. The method applies therapeutic agent and ultrasonic waves to the vascular area, lung or any body lumen without requiring direct contact between ultrasound transducer and body, dissolves blood clots, and stimulates tissue cells.
대표청구항
▼
An ultrasonic catheter drug delivery device comprises an ultrasound transducer to produce ultrasonic waves, which transducer is mechanically attached to a catheter body or chamber. The ultrasonic transducer has a distal tip with a distal radiation surface, and when a therapeutic agent from a fluid s
An ultrasonic catheter drug delivery device comprises an ultrasound transducer to produce ultrasonic waves, which transducer is mechanically attached to a catheter body or chamber. The ultrasonic transducer has a distal tip with a distal radiation surface, and when a therapeutic agent from a fluid source is directed to the catheter body or chamber, the radiation surface creates ultrasonic pressure and delivers liquid and simultaneously ultrasonic energy to a patient's vascularity or a selected body lumen. The method applies therapeutic agent and ultrasonic waves to the vascular area, lung or any body lumen without requiring direct contact between ultrasound transducer and body, dissolves blood clots, and stimulates tissue cells. ssociation, 252-253, (1993). Cohn, J.N., "Pharacologic Mechanisms of Nitrates in Myocardial Ischemia", American Journal of Cardiology, 70, 38G-42G, (Nov., 1992). Cohn, J.N., "Structural Changes in Cardiovascular Disease", Am. J. Cardiol., 76, 34E-37E, (1995). Cohn, J.N., "The Role of Vascular Compliance in Abnormalities of Hypertension and Atherosclerosis", Atherosclerosis Beyond Cholesteral, Monograph from Proceedings of a Symposium by the Council on Hypertension and Atherosclerosis Education, La Quinta, CA, Jan., 1991, 55-60, (1992). Cohn, J.N., et al., "Abnormalities of Vascular Compliance in Hypertension, Aging and Heart Failure", Journal of Hypertension, 10 (Suppl. 6), Abstract and Presentation at the Int'l Soc. of Hypertension Workshop on Arterial Compliance, "Functional and Structural Properties of Large Arteries", Paris, Mar. 6-7, 1992, S61-S64, (1992). Cohn, J.N., et al., "Measurement of Vascular Compliance as a Guide to Vasoconstrictor and Vasodilator Stimuli", Blood Vessels, 20, 189, (1983). Cohn, J.N., et al., "Noninvasive Pulse wave Analysis for the early detection of Vascular Disease", Hypertension, 26, 503-508, (Sep., 1995). Cohn, J.N., et al., "Vascular Complaince in Heart Failure: A Contributor to Impedance, and the Response to Vasodilator Drugs", In: Heart Failure Mechanisms and Management, B. S. Lewis and A. Kimchi, (eds.), Springer-Verlag, N.Y., 1991, pp. 42-44. Collins, V.R., et al., "Evaluation of a Pulse Contour Technique for Measuring Arterial Elasticity", Circulation, 62, Suppl. II, III-1120, (1980). Cundick, Jr., R.M., et al., "Clinical Comparison of Pressure-Pulse and Indicator-Dilution Cardiac Output determination", Circulation, 62, 371-376, (1980). Ekman, L.G., et al., "Clinical Evaluation of an Ensemble-Averaging Impedance Cardiograph for Monitoring Stroke Volume During Spontaneous Breathing", Acta Anaesthesiol Scand, 34, 190-196, (1990). English, J.B., et al., "Comparison of Aortic Pulse-Wave Contour Analysis and Thermodilution Methods of Measuring Cardiac Output During Anesthesia in the Dog", Anesthesiology, 52, 56-61, (1981). Feske, W., et al., "Arterial Vascular Compliance Response to Exercise in Hypertension", Biomedical Sciences Instrumentation, 24, 161-165, (1988). Feske, W., et al., "Reduced Arterial Compliance in Hypertension", Hypertension, 12, Presented at High Blood Pressure Research Council (Amer. Heart Assn.) meeting in San Francisco, Sep., 1988, 343, (Sep., 1988). Feske, W., et al., "Vascular Compliance after Nitroprusside in Hypertension", IEEE Proceedings, 14, 14th Annual N.E. Bioengineer. Symp., 277-280, (1988). Finkelstein, S.M., "Compliance Measurements Using Pulse Wave Analysis", The Atherosclerotic Blood Vessel, Structural and Functional Assessment of the Atherosclerotic Blood Vessel, San Francisco, Jul., 1993, 32-33, (1993). Finkelstein, S.M., et al., "A Comparison of Invasive and Non-Invasive Blood Pressure Measurements for Determining Arterial Vascular Compliance", Proceedings of the Annual Int'l. Conference of the IEEE Engineering in Medicine and Biology Society, 13, 2073-2074, (1991). Finkelstein, S.M., et al., "Arterial Vascular Compliance in Heart Failure", IEEE Engineering in Medicine and Biology Society Proceedings, 12, 548-549, (Nov., 1990). Finkelstein, S.M., et al., "Arterial Vascular Compliance Response to Vasodilators by Fourier and Pulse Contour Analysis", Hypertension, 12, 380-387, (1988). Finkelstein, S.M., et al., "Assessment of Vasodilators in the Time and frequency Domains", Update in Cardiac Surgery, Anesthesia and Intensive Care, 2nd International Symposium, Ghent, Sep. 21-24, 1993, 47-49, (1993). Finkelstein, S.M., et al., "Determining Stroke Volume from Arterial Blood Pressure Contour Analysis", Clinical Research, 40, 438A, (1992). Finkelstein, S.M., et al., "Evidence for Abnormal Vascular Compliance by Pulse Contour Analysis in Congestive Heart Failure", Circulation, 66, Suppl. II, 1109, (1982). Finkelstein, S.M., et al., "First and Third-Order Models for Determining Arterial Compliance", Int'l. Soc. of Hypertension Workshop on Arterial Compliance, Functional and Structural Properties of Large Arteries, Paris, Mar. 6-7, 1992, Abstract. Finkelstein, S.M., et al., "First and Third-Order Models for Determining Arterial Compliance", Journal of Hypertension, 10 (Suppl. 6,) S11-S14, (1992). Finkelstein, S.M., et al., "Impedance Response to Nitroprusside in Heart failure", Proceedings Engineering in Medicine and Biology, 26, 37th Annual Conf., 259, (1984). Finkelstein, S.M., et al., "Reproducibility of Vascular Compliance Measurements", IEEE Engineering in Medicine and Biology Society Proceedings, 11, 116-117, (1989). Finkelstein, S.M., et al., "Response of Vascular Compliance to Converting Enzyme Inhibitors in Heart Failure", A.A.M.I. Proceed., 20, 29, (1985). Finkelstein, S.M., et al., "Selective Effects of Left Ventricular Failure and Aging on Vascular Compliance", Circulation, 82, Suppl. III, III-4000, (1990). Finkelstein, S.M., et al., "Vascular Compliance in Congestive Heart Failure", Proceedings of the 7th Annual Conf. (Chicago, Il) of the IEEE Engineering in Medicine and Biology Society, 7, 550-553, (1985). Finkelstein, S.M., et al., "Vascular Compliance in Hypertension", IEEE Engineering in Medicine and Biology Society, 10, 10th Annual Int'l. Conf. Proceed., 241-242, (1988). Finkelstein, S.M., et al., "Vascular Compliance Response to Converting Enzyme Inhibitors in Heart Failure", Circulation, 76 (Suppl. 4), 178, (1987). Finkelstein, S.M., et al., "Vascular Hemodynamic Impedance in Congestive Heart Failure", American Journal of Cardiology, 55, 423-427, (1985). Finkelstein, S.M., et al., "Vascular Hemodynamic Impedance Measurement Methods", Progress in Cardiovascular Diseases, 24, 401-418, (1982). Finkelstein, S.M., et al., "Vascular Impedance by Pulse-Contour/Windkessel Analysis", A.A.M.I. Proceed., 19, 27, (1984). Finkelstein, S.M., et al., "Vascular Impedance in Health, Hypertension, and Heart Failure", Proceedings Engineering in Medicine and Biology, 25, 36th Annual Conf., 202, (1983). Finkelstein, S.M., et al., "Vascular Impedance Methodology in Congestive Heart Failure", Alliance of Engineering in Medicine and Biology Proceedings, 24, 35th Annual Conf., 143, (1982). Finkelstein, S.M., et al., "Vascular Impedance Response to Vasodilator Drugs", Alliance of Engineering in Medicine and Biology Proceedings, 23, 346, (1981). Finkelstein, S.M., et al., "Vasodilator Effects On VAscular Impedance Characteristics", Federation Proceedings, Part II of 3, vol. 38, No. 3 from 63rd Annual Meeting Apr. 1, 1979, 991, (1979). Goldwyn, R.M., et al., "Arterial Pressure Pulse Contour Analysis Via a Mathmatical Model for the Clinical Quantification of Human Vascular Properties", Transactions on Biomedical Engineering, BME-14(1), (1967). Haidet, G.C., et al., "Effects of Aging on Arterial Compliance in the Beagle", Clinical Research, 40, 266A, (1992). Harley, A., et al., "Pressure-Flow Studies in Man. An Evaluation of the Duration of the Phases of the Systole", The Journal of Clinical Investigation, 48, 895-905, (1969). Herd, J.A., et al., "Arterial Pressure Pulse Contours During Hemorrahage in Anesthetized Dogs", J. Appl. Physiol., 21, 1864-1868, (1966). Holmgren, A., et al., "Circulatory Data in Normal Subjects at Rest and During Exercise in Recumbent Position, with Specific Reference to the Stroke Volume at Different Work Intensities", Acta Physiol. Scand., 49, 343-363, (1966). Holvey, D.N., et al., The Merck Manual of Diagnosis and Therapy, 12th Edition, Reproduced from W. Brothby and R. B. Sandford, Boston Medical and Surgical Journal, vol. 185, p. 337, 1921, p. 1840, (1972). Kouchoukos, N.T., et al., "Estimation of Stroke Volume in the Dog by a Pulse Contour Method", Circulation Research, 26, 611-623, (1960). Krovetz, L.J., "Normal Standards for Cardiovascular Data I. Examination of the Validity of Cardiac Index", John Hopkins Medical Jo
※ AI-Helper는 부적절한 답변을 할 수 있습니다.